|
US5853719A
(en)
*
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
DE19743497A1
(de)
*
|
1996-10-01 |
1998-08-20 |
Geron Corp |
Katalytische Untereinheit menschlicher Telomerase
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6251665B1
(en)
*
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
AU3456099A
(en)
|
1998-03-31 |
1999-10-18 |
Geron Corporation |
Methods and compositions for eliciting an immune response to a telomerase antigen
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
*
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
AU2002258379A1
(en)
*
|
2000-10-24 |
2002-09-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
EP1363931A4
(en)
*
|
2001-02-01 |
2004-04-07 |
Tanox Inc |
METHOD FOR THE PRODUCTION AND IDENTIFICATION OF MONOCLONAL ANTIBODIES AGAINST A LARGE NUMBER OF HUMAN ANTIGENS
|
|
DE10112851C1
(de)
*
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
WO2002087627A1
(en)
*
|
2001-04-27 |
2002-11-07 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated t cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
DE50214201D1
(de)
|
2001-06-05 |
2010-03-25 |
Curevac Gmbh |
Stabilisierte mRNA mit erhöhtem G/C-Gehalt, enkodierend für ein bakterielles Antigen sowie deren Verwendung
|
|
US7045335B2
(en)
*
|
2001-09-06 |
2006-05-16 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
AU2002347813A1
(en)
*
|
2001-10-04 |
2003-04-14 |
Carlos Estuardo Aguilar-Cordova |
Chimeric viral vectors for gene therapy
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
CA2491574A1
(en)
*
|
2002-07-05 |
2004-01-15 |
Duke University |
Angio-immunotherapy
|
|
WO2004016803A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Duke University |
Method of enhancing cd4+ t cell responses
|
|
CN103951745A
(zh)
|
2002-09-12 |
2014-07-30 |
肿瘤疗法科学股份有限公司 |
Kdr肽和包括该肽的疫苗
|
|
AU2003296439B2
(en)
*
|
2002-12-10 |
2009-05-07 |
Argos Therapeutics, Inc. |
In situ maturation of dendritic cells
|
|
DK1585812T3
(en)
|
2002-12-13 |
2017-04-10 |
Alphavax Inc |
MULTI-ANTI-ANTI-ANTI-VIRUS REPLICATE PARTICLES AND PROCEDURES
|
|
WO2004055167A2
(en)
*
|
2002-12-13 |
2004-07-01 |
Alphavax, Inc. |
Alphavirus particles and methods for preparation
|
|
EP1641927B1
(en)
*
|
2003-02-18 |
2015-07-08 |
Baylor College of Medicine |
Induced activation in dendritic cells
|
|
JP2006518219A
(ja)
*
|
2003-02-18 |
2006-08-10 |
マックスサイト インコーポレーティッド |
電気穿孔法による細胞への抗原の負荷方法
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
KR101518309B1
(ko)
*
|
2003-03-20 |
2015-05-08 |
알파벡스, 인크. |
개선된 알파바이러스 레플리콘 및 헬퍼 구축물
|
|
US7419674B2
(en)
*
|
2003-07-11 |
2008-09-02 |
Alpha Vax, Inc. |
Alpha virus-based cytomegalovirus vaccines
|
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
CN1882603A
(zh)
*
|
2003-11-25 |
2006-12-20 |
阿哥斯医疗公司 |
mRNA转染的抗原呈递细胞
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
WO2005084387A2
(en)
*
|
2004-03-02 |
2005-09-15 |
Tsuneya Ohno |
Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
|
|
EP1751289B1
(en)
*
|
2004-05-18 |
2009-01-14 |
Alphavax, Inc. |
Tc-83-derived alphavirus vectors, particles and methods
|
|
US20080293581A1
(en)
*
|
2004-05-24 |
2008-11-27 |
Rogler Charles E |
Rna Expression Microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
JP5058804B2
(ja)
|
2004-09-14 |
2012-10-24 |
アルゴス セラピューティクス，インコーポレイティド |
病原体の株非依存的増幅およびそれに対するワクチン
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
EP2325306B1
(en)
|
2005-02-25 |
2014-02-12 |
Oncotherapy Science, Inc. |
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
|
|
SI1855707T1
(sl)
|
2005-02-28 |
2012-07-31 |
Oncotherapy Science Inc |
Peptidi epitopov izpeljani iz receptorja vaskularnega endotelijskega rastnega faktorja in cepiva ki vsebujejo te peptide
|
|
KR20160045151A
(ko)
|
2005-04-08 |
2016-04-26 |
아르고스 쎄라퓨틱스 인코포레이티드 |
수지상 세포 조성물 및 방법
|
|
PL1910839T3
(pl)
|
2005-07-27 |
2016-11-30 |
|
Gen TOM34 związany z nowotworem okrężnicy
|
|
EP1951281B1
(en)
|
2005-10-17 |
2015-04-15 |
Sloan Kettering Institute For Cancer Research |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
|
US9265816B2
(en)
|
2006-04-10 |
2016-02-23 |
Sloan Kettering Institute For Cancer Research |
Immunogenic WT-1 peptides and methods of use thereof
|
|
EP2010659B1
(en)
|
2006-04-14 |
2014-06-18 |
CellScript, Inc. |
Kits and methods for generating 5' capped RNA
|
|
JP5570808B2
(ja)
|
2006-08-18 |
2014-08-13 |
アルゴス・セラピューティクス・インコーポレーテッド |
併用療法におけるｃｄ８３の使用
|
|
SG175566A1
(en)
|
2006-10-17 |
2011-11-28 |
Oncotherapy Science Inc |
Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
|
|
WO2008049113A2
(en)
*
|
2006-10-19 |
2008-04-24 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI596109B
(zh)
|
2007-02-21 |
2017-08-21 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
EP2183368B1
(en)
*
|
2007-06-21 |
2016-08-10 |
Alphavax, Inc. |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
EP4032899A1
(en)
|
2007-08-20 |
2022-07-27 |
Oncotherapy Science, Inc. |
Foxm1 peptide and medicinal agent comprising the same
|
|
WO2009108341A1
(en)
|
2008-02-28 |
2009-09-03 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
JP2011525191A
(ja)
|
2008-06-20 |
2011-09-15 |
デユーク・ユニバーシテイ |
免疫応答を誘発するための組成物、方法およびキット
|
|
JP6133538B2
(ja)
|
2008-09-22 |
2017-05-24 |
ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ |
Ｃｄ４０およびパターン認識受容体アダプターを誘発することによる免疫応答を生成するための方法および組成物
|
|
DK2352756T3
(da)
|
2008-11-24 |
2012-12-03 |
Helmholtz Zentrum Muenchen |
Højaffin T-cellereceptor og anvendelse af denne
|
|
TWI500932B
(zh)
|
2008-12-05 |
2015-09-21 |
Oncotherapy Science Inc |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
WO2010065876A2
(en)
|
2008-12-06 |
2010-06-10 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
US9841426B2
(en)
*
|
2009-03-11 |
2017-12-12 |
Marker Gene Technologies, Inc |
Intracellular organelle peptide targeted enzyme substrates
|
|
RU2733985C2
(ru)
|
2009-03-18 |
2020-10-09 |
Онкотерапи Сайенс, Инк. |
Пептиды neil3 и включающие их вакцины
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
WO2011111392A1
(en)
|
2010-03-11 |
2011-09-15 |
Oncotherapy Science, Inc. |
Hjurp peptides and vaccines including the same
|
|
TW201627003A
(zh)
|
2010-04-02 |
2016-08-01 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE19177059T1
(de)
|
2010-10-01 |
2021-10-07 |
Modernatx, Inc. |
N1-methyl-pseudouracile enthältendes ribonucleinsäuren sowie ihre verwendungen
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
DK2742133T3
(en)
|
2011-08-12 |
2017-12-04 |
Oncotherapy Science Inc |
MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THESE
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
HUE057725T2
(hu)
|
2011-10-03 |
2022-06-28 |
Modernatx Inc |
Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
|
|
KR102020491B1
(ko)
|
2011-10-28 |
2019-09-10 |
온코세라피 사이언스 가부시키가이샤 |
Ｔｏｐｋ 펩티드 및 이를 포함하는 백신
|
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
|
EP2802347B1
(en)
|
2012-01-13 |
2019-01-09 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
JP2015516143A
(ja)
|
2012-04-02 |
2015-06-08 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ヒト疾患に関連するタンパク質の産生のための修飾ポリヌクレオチド
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
WO2014010231A1
(en)
|
2012-07-10 |
2014-01-16 |
Oncotherapy Science, Inc. |
Kif20a epitope peptides for th1 cells and vaccines containing the same
|
|
SMT202200337T1
(it)
|
2012-11-26 |
2022-09-14 |
Modernatx Inc |
Rna modificato al livello del terminale
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
CA2898099C
(en)
|
2013-01-15 |
2025-09-16 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 Peptides and Their Methods of Use
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
SG11201506974XA
(en)
|
2013-03-14 |
2015-10-29 |
Bellicum Pharmaceuticals Inc |
Methods for controlling t cell proliferation
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
EP3004329B1
(en)
|
2013-06-05 |
2020-03-04 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
EP3049092A4
(en)
|
2013-09-24 |
2017-09-06 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
WO2015051214A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
CA2937750A1
(en)
|
2014-02-14 |
2015-08-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating t cells using an inducible chimeric polypeptide
|
|
US12214038B2
(en)
*
|
2014-07-22 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
KR102489834B1
(ko)
|
2014-08-04 |
2023-01-19 |
온코세라피 사이언스 가부시키가이샤 |
Koc1-유래 펩티드 및 이를 포함하는 백신
|
|
CA2956265C
(en)
|
2014-08-04 |
2023-03-21 |
Oncotherapy Science, Inc. |
Urlc10-derived peptide and vaccine containing same
|
|
CN113321703A
(zh)
|
2014-08-04 |
2021-08-31 |
肿瘤疗法科学股份有限公司 |
Cdca1衍生的肽和含有它们的疫苗
|
|
EP3189148A4
(en)
|
2014-09-02 |
2018-05-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
US10987412B2
(en)
*
|
2014-09-17 |
2021-04-27 |
The John Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells
|
|
CA2965347C
(en)
*
|
2014-10-27 |
2023-03-14 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy
|
|
CA2966300C
(en)
|
2014-11-03 |
2023-07-11 |
Mirjam H.M. Heemskerk |
T cell receptors directed against bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
HK1251924A1
(en)
|
2015-10-08 |
2019-05-03 |
Oncotherapy Science, Inc. |
Foxm1-derived peptide, and vaccine including same
|
|
EP3410849B1
(en)
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
WO2017192924A1
(en)
|
2016-05-04 |
2017-11-09 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
|
JP2019519589A
(ja)
*
|
2016-06-29 |
2019-07-11 |
デューク ユニバーシティー |
キメラポリオウイルスで抗原提示細胞を活性化するための組成物及び方法
|
|
US20210069310A1
(en)
*
|
2018-01-05 |
2021-03-11 |
Rolf Jonas Andreas NILSSON |
Endogenous tumor-derived circular rna and proteins thereof for use as vaccine
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
US20250144143A1
(en)
*
|
2023-11-06 |
2025-05-08 |
Immunitybio, Inc. |
Virally Educated T cells
|